Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Ferritin light chain | 12 | 0 | 0 | 12 |
glp-1 receptor, partial | 20 | 0 | 0 | 20 |
phosphopantetheinyl transferase | 31 | 0 | 0 | 31 |
hypoxia-inducible factor 1 alpha subunit | 22 | 0 | 0 | 22 |
RAR-related orphan receptor gamma | 66 | 0 | 0 | 66 |
SMAD family member 2 | 20 | 0 | 0 | 20 |
Fumarate hydratase | 9 | 0 | 0 | 9 |
SMAD family member 3 | 20 | 0 | 0 | 20 |
TDP1 protein | 71 | 0 | 0 | 71 |
GLI family zinc finger 3 | 77 | 0 | 0 | 77 |
Microtubule-associated protein tau | 40 | 0 | 0 | 40 |
AR protein | 84 | 0 | 0 | 84 |
Smad3 | 13 | 0 | 0 | 13 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 19 | 0 | 0 | 19 |
estrogen receptor 2 (ER beta) | 35 | 0 | 0 | 35 |
nuclear receptor subfamily 1, group I, member 3 | 62 | 0 | 0 | 62 |
progesterone receptor | 44 | 0 | 0 | 44 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 60 | 0 | 0 | 60 |
glucocorticoid receptor [Homo sapiens] | 62 | 0 | 0 | 62 |
retinoic acid nuclear receptor alpha variant 1 | 64 | 0 | 0 | 64 |
retinoid X nuclear receptor alpha | 48 | 0 | 0 | 48 |
estrogen-related nuclear receptor alpha | 75 | 0 | 0 | 75 |
farnesoid X nuclear receptor | 41 | 0 | 0 | 41 |
pregnane X nuclear receptor | 59 | 0 | 0 | 59 |
estrogen nuclear receptor alpha | 99 | 0 | 0 | 99 |
G | 42 | 0 | 0 | 42 |
cytochrome P450 2D6 | 37 | 0 | 0 | 37 |
polyprotein | 9 | 0 | 0 | 9 |
67.9K protein | 21 | 0 | 0 | 21 |
bromodomain adjacent to zinc finger domain 2B | 18 | 0 | 0 | 18 |
peroxisome proliferator-activated receptor delta | 34 | 0 | 0 | 34 |
peroxisome proliferator activated receptor gamma | 40 | 0 | 0 | 40 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 43 | 0 | 0 | 43 |
IDH1 | 26 | 0 | 0 | 26 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 39 | 0 | 0 | 39 |
thyroid stimulating hormone receptor | 21 | 0 | 0 | 21 |
activating transcription factor 6 | 26 | 0 | 0 | 26 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 23 | 0 | 0 | 23 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 33 | 0 | 0 | 33 |
Histone H2A.x | 24 | 0 | 0 | 24 |
Caspase-7 | 8 | 0 | 0 | 8 |
vitamin D3 receptor isoform VDRA | 25 | 0 | 0 | 25 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 23 | 0 | 0 | 23 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 9 | 0 | 0 | 9 |
caspase-3 | 8 | 0 | 0 | 8 |
thyroid hormone receptor beta isoform 2 | 54 | 0 | 0 | 54 |
heat shock protein beta-1 | 24 | 0 | 0 | 24 |
huntingtin isoform 2 | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 66 | 0 | 0 | 66 |
nuclear receptor ROR-gamma isoform 1 | 22 | 0 | 0 | 22 |
geminin | 73 | 0 | 0 | 73 |
survival motor neuron protein isoform d | 21 | 0 | 0 | 21 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
lamin isoform A-delta10 | 69 | 0 | 0 | 69 |
neuropeptide S receptor isoform A | 10 | 0 | 0 | 10 |
Voltage-dependent calcium channel gamma-2 subunit | 35 | 0 | 0 | 35 |
Interferon beta | 54 | 0 | 0 | 54 |
HLA class I histocompatibility antigen, B alpha chain | 42 | 0 | 0 | 42 |
Cellular tumor antigen p53 | 55 | 0 | 0 | 55 |
Glutamate receptor 2 | 35 | 0 | 0 | 35 |
Alpha-synuclein | 5 | 3 | 0 | 8 |
Spike glycoprotein | 37 | 2 | 3 | 42 |
Guanine nucleotide-binding protein G | 11 | 0 | 0 | 11 |
Inositol hexakisphosphate kinase 1 | 42 | 0 | 0 | 42 |
cytochrome P450 2C9, partial | 42 | 0 | 0 | 42 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 37 | 0 | 0 | 37 |
GLS protein | 35 | 0 | 0 | 35 |
cytochrome P450 2C9 precursor | 19 | 0 | 0 | 19 |
chromobox protein homolog 1 | 49 | 0 | 0 | 49 |
potassium voltage-gated channel subfamily H member 2 isoform d | 24 | 0 | 0 | 24 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 9 | 0 | 0 | 9 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 5 | 0 | 0 | 5 |
ATP-binding cassette sub-family C member 3 | 0 | 74 | 0 | 74 |
Multidrug resistance-associated protein 4 | 0 | 74 | 0 | 76 |
Bile salt export pump | 0 | 106 | 0 | 106 |
Transthyretin | 0 | 0 | 2 | 4 |
Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 25 | 0 | 1 | 27 |
Disintegrin and metalloproteinase domain-containing protein 17 | 6 | 0 | 0 | 6 |
ATAD5 protein, partial | 31 | 0 | 0 | 31 |
aldehyde dehydrogenase 1 family, member A1 | 55 | 0 | 0 | 55 |
thyroid stimulating hormone receptor | 37 | 0 | 0 | 37 |
EWS/FLI fusion protein | 38 | 0 | 0 | 38 |
aryl hydrocarbon receptor | 33 | 0 | 0 | 33 |
peripheral myelin protein 22 | 37 | 0 | 0 | 37 |
cytochrome P450 3A4 isoform 1 | 36 | 0 | 0 | 36 |
Gamma-aminobutyric acid receptor subunit pi | 36 | 9 | 3 | 48 |
Solute carrier family 22 member 6 | 0 | 16 | 0 | 17 |
Carbonic anhydrase 12 | 0 | 12 | 1 | 20 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 4 |
Bile salt export pump | 0 | 19 | 0 | 19 |
Cytochrome P450 2B1 | 0 | 1 | 0 | 2 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 39 | 1 | 49 |
Carbonic anhydrase 2 | 0 | 41 | 3 | 52 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 3 | 1 | 5 |
Cytochrome P450 1A2 | 0 | 10 | 0 | 12 |
Prostaglandin G/H synthase 1 | 0 | 11 | 0 | 12 |
Carbonic anhydrase 3 | 0 | 12 | 1 | 17 |
Cytochrome P450 3A4 | 0 | 23 | 2 | 27 |
Cytochrome P450 2D6 | 0 | 15 | 0 | 15 |
Cytochrome P450 2C9 | 0 | 28 | 0 | 29 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 7 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-1 | 36 | 9 | 3 | 48 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 36 | 9 | 3 | 48 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 36 | 9 | 3 | 48 |
UDP-glucuronosyltransferase 1-6 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 36 | 9 | 3 | 48 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 36 | 9 | 3 | 48 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 4 | 0 | 4 |
UDP-glucuronosyltransferase 1A1 | 0 | 5 | 0 | 7 |
Carbonic anhydrase 4 | 0 | 24 | 1 | 31 |
Prostaglandin G/H synthase 1 | 0 | 14 | 0 | 15 |
Carbonic anhydrase 6 | 0 | 16 | 1 | 23 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 36 | 9 | 3 | 48 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 36 | 9 | 3 | 48 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 36 | 9 | 3 | 48 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 36 | 9 | 3 | 48 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 36 | 9 | 3 | 48 |
Carbonic anhydrase 5A, mitochondrial | 0 | 16 | 3 | 26 |
Prostaglandin G/H synthase 2 | 0 | 16 | 2 | 20 |
Carbonic anhydrase 7 | 0 | 12 | 1 | 19 |
Nuclear receptor ROR-gamma | 19 | 0 | 0 | 19 |
Cytochrome P450 2J2 | 0 | 19 | 0 | 19 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 36 | 11 | 3 | 50 |
Gamma-aminobutyric acid receptor subunit beta-3 | 36 | 9 | 3 | 48 |
Gamma-aminobutyric acid receptor subunit beta-2 | 36 | 9 | 3 | 48 |
Carbonic anhydrase 9 | 0 | 18 | 1 | 26 |
GABA theta subunit | 36 | 9 | 3 | 48 |
Canalicular multispecific organic anion transporter 1 | 0 | 69 | 0 | 69 |
Carbonic anhydrase 15 | 0 | 14 | 0 | 15 |
Carbonic anhydrase 13 | 0 | 7 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit epsilon | 36 | 9 | 3 | 48 |
Carbonic anhydrase 14 | 0 | 12 | 1 | 20 |
Carbonic anhydrase 5B, mitochondrial | 0 | 13 | 1 | 21 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 23 | 0 | 0 | 23 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 28 | 0 | 0 | 28 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Carbonic anhydrase | 0 | 7 | 0 | 7 |
thioredoxin reductase | 44 | 0 | 0 | 44 |
GALC protein | 5 | 0 | 0 | 5 |
Carbonic anhydrase | 0 | 6 | 0 | 6 |
Carbonic anhydrase | 0 | 5 | 0 | 5 |
arylsulfatase A | 26 | 0 | 0 | 26 |
Carbonic anhydrase | 0 | 5 | 0 | 5 |
euchromatic histone-lysine N-methyltransferase 2 | 87 | 0 | 0 | 87 |
Bloom syndrome protein isoform 1 | 20 | 0 | 0 | 20 |
thyroid hormone receptor beta isoform a | 23 | 0 | 0 | 23 |
muscleblind-like protein 1 isoform 1 | 14 | 0 | 0 | 14 |
Carbonic anhydrase | 0 | 4 | 0 | 4 |
Prolyl endopeptidase | 0 | 4 | 0 | 4 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 3 |
Glycogen phosphorylase, muscle form | 0 | 3 | 0 | 3 |
Renin | 0 | 4 | 0 | 4 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 3 |
Cathepsin B | 0 | 2 | 0 | 2 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 5 | 0 | 5 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 5 | 0 | 5 |
Cytochrome P450 2C8 | 0 | 6 | 0 | 6 |
Cytochrome P450 2A6 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 8 | 1 | 9 |
Androgen receptor | 0 | 13 | 0 | 13 |
Translocator protein | 0 | 4 | 2 | 7 |
Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
Cytochrome P450 2B6 | 0 | 8 | 2 | 10 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 3 |
Adenosine receptor A1 | 0 | 11 | 0 | 13 |
Serum paraoxonase/arylesterase 1 | 0 | 5 | 0 | 5 |
Dipeptidyl peptidase 4 | 0 | 2 | 0 | 4 |
Endochitinase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 11 | 1 | 16 |
5-hydroxytryptamine receptor 2B | 0 | 5 | 0 | 5 |
Sodium-dependent serotonin transporter | 0 | 5 | 1 | 6 |
Delta-type opioid receptor | 0 | 10 | 0 | 12 |
Cytochrome P450 2C19 | 0 | 12 | 0 | 12 |
Delta-type opioid receptor | 0 | 12 | 2 | 15 |
Mu-type opioid receptor | 0 | 13 | 3 | 19 |
Carbonic anhydrase | 0 | 13 | 0 | 13 |
Kappa-type opioid receptor | 0 | 7 | 1 | 10 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 8 | 1 | 0 | 9 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 5 | 0 | 5 |
D(2) dopamine receptor | 0 | 9 | 0 | 9 |
Cholinesterase | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 5 | 0 | 5 |
Mu-type opioid receptor | 0 | 14 | 0 | 14 |
Fatty-acid amide hydrolase 1 | 0 | 5 | 0 | 5 |
Beta-carbonic anhydrase 1 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 5 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 8 | 2 | 10 |
Squalene synthase | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 6 | 0 | 6 |
Carbonic anhydrase | 0 | 5 | 0 | 5 |
Carbonic anhydrase 3 | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 4 | 0 | 5 |
Carbonic anhydrase | 0 | 6 | 0 | 7 |
Carbonic anhydrase | 0 | 6 | 0 | 6 |
Sigma intracellular receptor 2 | 0 | 4 | 0 | 4 |
Delta carbonic anhydrase | 0 | 6 | 0 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 5 | 0 | 5 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 9 | 1 | 11 |
Carbonic anhydrase 4 | 0 | 9 | 0 | 9 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 16 | 0 | 0 | 16 |
Chain A, 2-oxoglutarate Oxygenase | 30 | 0 | 0 | 30 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 7 | 0 | 0 | 7 |
acetylcholinesterase | 26 | 0 | 0 | 26 |
dopamine D1 receptor | 4 | 0 | 0 | 4 |
15-lipoxygenase, partial | 12 | 0 | 0 | 12 |
pregnane X receptor | 13 | 0 | 0 | 13 |
USP1 protein, partial | 46 | 0 | 0 | 46 |
NFKB1 protein, partial | 12 | 0 | 0 | 12 |
Thrombopoietin | 8 | 0 | 0 | 8 |
regulator of G-protein signaling 4 | 18 | 0 | 0 | 18 |
D(1A) dopamine receptor | 19 | 0 | 0 | 19 |
flap endonuclease 1 | 22 | 0 | 0 | 22 |
muscarinic acetylcholine receptor M1 | 23 | 0 | 0 | 23 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Histone deacetylase 1 | 0 | 2 | 0 | 2 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Ataxin-2 | 32 | 0 | 0 | 32 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
Histone deacetylase 6 | 0 | 2 | 0 | 2 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
ATP-dependent phosphofructokinase | 32 | 0 | 0 | 32 |
Choline O-acetyltransferase | 0 | 2 | 0 | 2 |
Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
importin subunit beta-1 isoform 1 | 9 | 0 | 0 | 9 |
snurportin-1 | 9 | 0 | 0 | 9 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 4 | 0 | 0 | 4 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-beta | 0 | 2 | 2 | 5 |
Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 3 |
TAR DNA-binding protein 43 | 13 | 0 | 0 | 13 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 21 | 0 | 0 | 21 |
interleukin 8 | 19 | 0 | 0 | 19 |
Nrf2 | 3 | 0 | 0 | 3 |
cellular tumor antigen p53 isoform a | 11 | 0 | 0 | 11 |
Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 0 | 3 | 3 | 6 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 4 |
Chain A, HADH2 protein | 24 | 0 | 0 | 24 |
Chain B, HADH2 protein | 24 | 0 | 0 | 24 |
glucocerebrosidase | 14 | 0 | 0 | 14 |
alpha-galactosidase | 7 | 0 | 0 | 7 |
lysosomal alpha-glucosidase preproprotein | 8 | 0 | 0 | 8 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 25 | 0 | 0 | 25 |
Alpha-1A adrenergic receptor | 0 | 6 | 4 | 10 |
Solute carrier family 22 member 1 | 0 | 22 | 0 | 24 |
Neuronal acetylcholine receptor subunit alpha-4 | 5 | 3 | 0 | 8 |
Neuronal acetylcholine receptor subunit beta-2 | 5 | 3 | 0 | 8 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 3 | 0 | 3 |
Alpha-1A adrenergic receptor | 0 | 8 | 1 | 9 |
Alpha-2B adrenergic receptor | 0 | 15 | 7 | 22 |
Alpha-2C adrenergic receptor | 0 | 14 | 7 | 21 |
Acetylcholinesterase | 0 | 8 | 0 | 8 |
Alpha-2A adrenergic receptor | 0 | 14 | 7 | 21 |
Alpha-1D adrenergic receptor | 0 | 21 | 6 | 28 |
Alpha-1D adrenergic receptor | 0 | 31 | 7 | 42 |
Alpha-1A adrenergic receptor | 0 | 19 | 12 | 37 |
Alpha-1B adrenergic receptor | 0 | 18 | 10 | 32 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 38 | 0 | 39 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 13 | 0 | 14 |
Sodium channel protein type 5 subunit alpha | 0 | 7 | 0 | 7 |
Potassium voltage-gated channel subfamily D member 3 | 0 | 2 | 0 | 2 |
transcriptional regulator ERG isoform 3 | 7 | 0 | 0 | 7 |
ras-related protein Rab-9A | 10 | 0 | 0 | 10 |
Polyphenol oxidase 2 | 0 | 3 | 0 | 3 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 2 |
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 8 | 6 | 16 |
Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 2 | 1 | 5 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Shiga toxin subunit A | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Luciferase | 29 | 0 | 0 | 29 |
histone deacetylase 9 isoform 3 | 7 | 0 | 0 | 7 |
Nicotinate phosphoribosyltransferase | 0 | 7 | 0 | 7 |
ORF73 | 0 | 0 | 4 | 4 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
apical membrane antigen 1, AMA1 | 6 | 0 | 0 | 6 |
Beta-lactamase | 0 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 13 | 0 | 0 | 13 |
DNA polymerase eta isoform 1 | 8 | 0 | 0 | 8 |
DNA polymerase iota isoform a (long) | 26 | 0 | 0 | 26 |
urokinase-type plasminogen activator precursor | 12 | 0 | 0 | 12 |
plasminogen precursor | 12 | 0 | 0 | 12 |
urokinase plasminogen activator surface receptor precursor | 12 | 0 | 0 | 12 |
DNA polymerase kappa isoform 1 | 22 | 0 | 0 | 22 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 1 | 0 | 7 | 0 | 7 |
Solute carrier family 15 member 1 | 0 | 3 | 0 | 3 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 4 |
Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 4 | 0 | 5 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Chain A, Cruzipain | 13 | 0 | 0 | 13 |
Beta-lactamase | 0 | 1 | 0 | 2 |
acid sphingomyelinase | 3 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
DNA polymerase beta | 9 | 0 | 0 | 9 |
60 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 4 | 0 | 4 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 3 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 0 | 0 | 2 |
60 kDa chaperonin | 0 | 5 | 0 | 5 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
10 kDa chaperonin | 0 | 5 | 0 | 5 |
Metallo-b-lactamase | 0 | 0 | 0 | 4 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 2 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 4 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 3 |
histone acetyltransferase KAT2A isoform 1 | 24 | 0 | 0 | 24 |
Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 4 | 2 | 6 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 4 | 0 | 4 |
Type-1 angiotensin II receptor | 0 | 5 | 4 | 11 |
Type-2 angiotensin II receptor | 0 | 4 | 0 | 4 |
Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
cytochrome P450 2C19 precursor | 16 | 0 | 0 | 16 |
lethal factor (plasmid) | 20 | 0 | 0 | 20 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 11 | 0 | 0 | 11 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 4 | 0 | 0 | 4 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 2 | 0 | 2 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 28 | 3 | 34 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 3 | 3 |
ras protein, partial | 0 | 0 | 3 | 3 |
hypothetical protein, conserved | 5 | 0 | 0 | 5 |
Rac1 protein | 0 | 0 | 3 | 3 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 3 | 3 |
Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 7 |
Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 6 |
Epidermal growth factor receptor | 0 | 9 | 0 | 9 |
Fatty acid-binding protein, liver | 0 | 7 | 1 | 8 |
Integrin beta-3 | 7 | 1 | 0 | 8 |
Myeloperoxidase | 0 | 3 | 0 | 3 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 3 | 0 | 3 |
Integrin alpha-IIb | 7 | 1 | 0 | 8 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 3 | 0 | 3 |
Urotensin-2 receptor | 0 | 2 | 0 | 2 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 2 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 3 | 3 |
Prostaglandin G/H synthase 2 | 0 | 9 | 0 | 9 |
Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 18 | 2 | 20 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 3 | 6 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 32 | 1 | 33 |
Muscarinic acetylcholine receptor M2 | 0 | 14 | 2 | 20 |
Muscarinic acetylcholine receptor M4 | 0 | 16 | 1 | 20 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 3 | 10 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 3 | 9 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 3 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 3 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 15 | 1 | 19 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 4 | 12 |
Muscarinic acetylcholine receptor M1 | 0 | 15 | 2 | 21 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 13 | 2 | 18 |
5-hydroxytryptamine receptor 2C | 0 | 33 | 1 | 34 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 1 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 12 | 0 | 12 |
Reverse transcriptase/RNaseH | 0 | 1 | 3 | 8 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 3 |
Amyloid-beta precursor protein | 1 | 4 | 0 | 5 |
Microtubule-associated protein tau | 0 | 2 | 0 | 2 |
Chain A, Integrase | 0 | 1 | 0 | 1 |
Chain A, Integrase | 0 | 1 | 0 | 1 |
Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
Chain A, GCN4P1 | 0 | 0 | 1 | 1 |
Chain B, GCN4P1 | 0 | 0 | 1 | 1 |
Chain C, GCN4P1 | 0 | 0 | 1 | 1 |
Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
Chain A, Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Chain A, 3C-like proteinase | 0 | 1 | 0 | 1 |
Endolysin | 0 | 0 | 2 | 2 |
Dihydroorotate dehydrogenase | 0 | 2 | 0 | 2 |
Protease | 0 | 3 | 1 | 4 |
nuclear receptor subfamily 1, group I, member 2 | 14 | 0 | 0 | 14 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 12 | 2 | 19 |
Glycine receptor subunit alpha-1 | 0 | 12 | 0 | 12 |
Glycine receptor subunit beta | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-2 | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-3 | 0 | 12 | 0 | 12 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 16 | 0 | 0 | 16 |
caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
Caspase-7 | 3 | 0 | 0 | 3 |
Inositol monophosphatase 1 | 9 | 0 | 0 | 9 |
Solute carrier organic anion transporter family member 1B3 | 0 | 10 | 0 | 12 |
Solute carrier organic anion transporter family member 1B1 | 0 | 10 | 0 | 12 |
Potassium channel subfamily K member 3 | 0 | 4 | 0 | 4 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 4 | 5 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 13 | 4 | 18 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
Cholinesterase | 0 | 3 | 0 | 3 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 7 | 3 | 10 |
Adenosine receptor A3 | 0 | 11 | 1 | 12 |
Replicase polyprotein 1ab | 0 | 6 | 3 | 9 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 4 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 6 | 0 | 6 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Adenosine receptor A2b | 0 | 2 | 0 | 4 |
Adenosine receptor A2b | 0 | 5 | 0 | 7 |
Adenosine receptor A1 | 0 | 5 | 2 | 11 |
Vasopressin V2 receptor | 0 | 0 | 0 | 2 |
Serine/threonine-protein kinase mTOR | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 3 | 0 | 3 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 2 | 0 | 2 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 2 |
Chitotriosidase-1 | 0 | 2 | 0 | 2 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 3 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 3 | 4 |
Endochitinase B1 | 0 | 2 | 0 | 2 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 10 | 0 | 11 |
Guanine deaminase | 0 | 3 | 0 | 3 |
PPM1D protein | 10 | 0 | 0 | 10 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 5 | 1 | 6 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 28 | 4 | 35 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 0 | 3 |
D(1A) dopamine receptor | 0 | 18 | 1 | 19 |
Cytochrome P450 3A7 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 5 | 1 | 7 |
Cannabinoid receptor 2 | 0 | 2 | 1 | 4 |
Mu-type opioid receptor | 0 | 18 | 7 | 26 |
Peroxisome proliferator-activated receptor gamma | 0 | 1 | 3 | 4 |
Delta-type opioid receptor | 0 | 9 | 4 | 14 |
N-acylethanolamine-hydrolyzing acid amidase | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
Heat sensitive channel TRPV3 | 0 | 1 | 1 | 2 |
Sigma intracellular receptor 2 | 0 | 3 | 0 | 3 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 1 | 2 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 2 | 3 |
Transient receptor potential cation channel subfamily M member 8 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 1 | 2 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 2 | 1 | 3 |
G-protein coupled receptor 55 | 0 | 0 | 1 | 1 |
Diacylglycerol lipase-alpha | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 2 | 0 | 2 |
mitogen-activated protein kinase 1 | 20 | 0 | 0 | 20 |
Vpr | 3 | 0 | 0 | 3 |
Albumin | 0 | 0 | 5 | 5 |
Major prion protein | 0 | 0 | 3 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 3 | 0 | 8 |
Sodium channel protein type 4 subunit alpha | 0 | 4 | 0 | 5 |
Sodium channel protein type 9 subunit alpha | 0 | 4 | 0 | 4 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 2 | 0 | 2 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 3 |
Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 10 | 0 | 0 | 10 |
caspase-3 | 10 | 0 | 0 | 10 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
interferon gamma precursor | 0 | 0 | 0 | 3 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 2 |
Prostaglandin E synthase | 0 | 2 | 0 | 2 |
3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 5 | 1 | 6 |
Cytochrome c oxidase subunit 1 | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 3 | 0 | 3 |
Procathepsin L | 0 | 4 | 3 | 7 |
Aldo-keto reductase family 1 member B1 | 0 | 16 | 0 | 16 |
Quinolone resistance protein NorA | 0 | 2 | 0 | 3 |
Beta-3 adrenergic receptor | 0 | 7 | 3 | 10 |
Alpha-1B adrenergic receptor | 0 | 26 | 6 | 32 |
Calpain-2 catalytic subunit | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 21 | 3 | 25 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Sodium-dependent noradrenaline transporter | 0 | 18 | 0 | 18 |
Cruzipain | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 3 | 0 | 3 |
Sodium-dependent serotonin transporter | 0 | 14 | 0 | 14 |
Bifunctional epoxide hydrolase 2 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 6 | 0 | 7 |
Alpha-1A adrenergic receptor | 0 | 30 | 7 | 37 |
Sodium-dependent dopamine transporter | 0 | 14 | 0 | 14 |
Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 6 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 7 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Cyclooxygenase-2 | 0 | 2 | 0 | 2 |
Rap guanine nucleotide exchange factor 4 | 4 | 0 | 0 | 4 |
P2Y purinoceptor 12 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
streptokinase A precursor | 0 | 0 | 5 | 5 |
30S ribosomal protein S6 | 0 | 3 | 0 | 3 |
30S ribosomal protein S7 | 0 | 3 | 0 | 3 |
50S ribosomal protein L15 | 0 | 3 | 0 | 3 |
50S ribosomal protein L10 | 0 | 3 | 0 | 3 |
50S ribosomal protein L11 | 0 | 3 | 0 | 3 |
50S ribosomal protein L7/L12 | 0 | 3 | 0 | 3 |
50S ribosomal protein L19 | 0 | 3 | 0 | 3 |
50S ribosomal protein L1 | 0 | 3 | 0 | 3 |
50S ribosomal protein L20 | 0 | 3 | 0 | 3 |
50S ribosomal protein L27 | 0 | 3 | 0 | 3 |
50S ribosomal protein L28 | 0 | 3 | 0 | 3 |
50S ribosomal protein L29 | 0 | 3 | 0 | 3 |
50S ribosomal protein L31 | 0 | 3 | 0 | 3 |
50S ribosomal protein L31 type B | 0 | 3 | 0 | 3 |
50S ribosomal protein L32 | 0 | 3 | 0 | 3 |
50S ribosomal protein L33 | 0 | 3 | 0 | 3 |
50S ribosomal protein L34 | 0 | 3 | 0 | 3 |
50S ribosomal protein L35 | 0 | 3 | 0 | 3 |
50S ribosomal protein L36 | 0 | 3 | 0 | 3 |
30S ribosomal protein S10 | 0 | 3 | 0 | 3 |
30S ribosomal protein S11 | 0 | 3 | 0 | 3 |
30S ribosomal protein S12 | 0 | 3 | 0 | 3 |
30S ribosomal protein S13 | 0 | 3 | 0 | 3 |
30S ribosomal protein S16 | 0 | 3 | 0 | 3 |
30S ribosomal protein S18 | 0 | 3 | 0 | 3 |
30S ribosomal protein S19 | 0 | 3 | 0 | 3 |
30S ribosomal protein S20 | 0 | 3 | 0 | 3 |
30S ribosomal protein S2 | 0 | 3 | 0 | 3 |
30S ribosomal protein S3 | 0 | 3 | 0 | 3 |
30S ribosomal protein S4 | 0 | 3 | 0 | 3 |
30S ribosomal protein S5 | 0 | 3 | 0 | 3 |
30S ribosomal protein S8 | 0 | 3 | 0 | 3 |
30S ribosomal protein S9 | 0 | 3 | 0 | 3 |
50S ribosomal protein L13 | 0 | 3 | 0 | 3 |
50S ribosomal protein L14 | 0 | 3 | 0 | 3 |
50S ribosomal protein L16 | 0 | 3 | 0 | 3 |
50S ribosomal protein L23 | 0 | 3 | 0 | 3 |
30S ribosomal protein S15 | 0 | 3 | 0 | 3 |
50S ribosomal protein L17 | 0 | 3 | 0 | 3 |
50S ribosomal protein L21 | 0 | 3 | 0 | 3 |
50S ribosomal protein L30 | 0 | 3 | 0 | 3 |
50S ribosomal protein L6 | 0 | 3 | 0 | 3 |
30S ribosomal protein S14 | 0 | 3 | 0 | 3 |
30S ribosomal protein S17 | 0 | 3 | 0 | 3 |
30S ribosomal protein S1 | 0 | 3 | 0 | 3 |
50S ribosomal protein L18 | 0 | 3 | 0 | 3 |
50S ribosomal protein L2 | 0 | 3 | 0 | 3 |
50S ribosomal protein L3 | 0 | 3 | 0 | 3 |
50S ribosomal protein L24 | 0 | 3 | 0 | 3 |
50S ribosomal protein L4 | 0 | 3 | 0 | 3 |
50S ribosomal protein L22 | 0 | 3 | 0 | 3 |
50S ribosomal protein L5 | 0 | 3 | 0 | 3 |
30S ribosomal protein S21 | 0 | 3 | 0 | 3 |
50S ribosomal protein L25 | 0 | 3 | 0 | 3 |
50S ribosomal protein L36 2 | 0 | 3 | 0 | 3 |
Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
PAX8 | 0 | 0 | 0 | 2 |
PINK1 | 1 | 0 | 0 | 1 |
Parkin | 8 | 0 | 0 | 8 |
heat shock protein 90 | 0 | 0 | 1 | 1 |
calcineurin A1, putative | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 isoform 1 | 15 | 0 | 0 | 15 |
hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 2 | 0 | 2 |
perilipin-5 | 0 | 4 | 0 | 4 |
perilipin-1 | 0 | 4 | 0 | 4 |
ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 3 | 0 | 0 | 3 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
melanocortin receptor 4 | 0 | 1 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 2 |
bcl-2-related protein A1 | 0 | 2 | 0 | 2 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 4 | 0 | 4 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
hexokinase HKDC1 | 0 | 1 | 0 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Synaptojanin-2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 6 | 0 | 7 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 11 | 0 | 0 | 11 |
Synaptojanin-1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 5 | 0 | 5 |
Glutathione reductase, mitochondrial | 0 | 6 | 0 | 7 |
72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
Trypanothione reductase | 0 | 3 | 0 | 3 |
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 4 | 0 | 4 |
Multidrug and toxin extrusion protein 1 | 0 | 12 | 0 | 12 |
Spermine oxidase | 0 | 1 | 0 | 1 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 3 | 0 | 3 |
Spike glycoprotein | 0 | 2 | 3 | 5 |
Replicase polyprotein 1ab | 0 | 4 | 4 | 8 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 3 | 0 | 3 |
Transmembrane protease serine 2 | 0 | 2 | 3 | 5 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
DNA ligase | 0 | 1 | 0 | 1 |
Riboflavin-binding protein | 0 | 0 | 1 | 1 |
Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 32 | 6 | 41 |
Replicase polyprotein 1a | 0 | 3 | 3 | 6 |
Replicase polyprotein 1ab | 0 | 3 | 3 | 6 |
Spike glycoprotein | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
DNA ligase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 1 | 1 | 2 |
Beta-secretase 1 | 0 | 2 | 0 | 2 |
Calcium-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
DNA ligase A | 0 | 1 | 0 | 1 |
Phosphoethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 2 | 3 | 5 |
Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
nonstructural protein 1 | 17 | 0 | 0 | 17 |
Snq2p | 0 | 0 | 0 | 3 |
D(2) dopamine receptor | 0 | 20 | 1 | 21 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 3 | 0 | 6 |
Histamine H1 receptor | 0 | 16 | 0 | 16 |
D(3) dopamine receptor | 0 | 22 | 0 | 22 |
5-hydroxytryptamine receptor 6 | 0 | 17 | 1 | 18 |
Beta-2 adrenergic receptor | 0 | 6 | 1 | 8 |
Beta-1 adrenergic receptor | 0 | 7 | 2 | 11 |
Dipeptidase 1 | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 4 | 2 | 6 |
Solute carrier family 22 member 6 | 0 | 9 | 0 | 12 |
Solute carrier family 22 member 8 | 0 | 8 | 0 | 11 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 5 | 0 | 7 |
DNA gyrase subunit A | 0 | 5 | 0 | 9 |
DNA gyrase subunit B | 0 | 5 | 1 | 9 |
DNA topoisomerase 4 subunit A | 0 | 2 | 0 | 2 |
DNA topoisomerase 4 subunit B | 0 | 2 | 0 | 3 |
DNA topoisomerase 4 subunit A | 0 | 2 | 0 | 3 |
DNA topoisomerase 2-alpha | 0 | 2 | 0 | 5 |
DNA gyrase subunit A | 0 | 5 | 0 | 7 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 5 | 0 | 6 |
DNA gyrase subunit A | 0 | 6 | 0 | 7 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 6 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 2 | 0 | 2 |
3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
ATP-citrate synthase | 0 | 0 | 0 | 1 |
Ribonuclease T | 0 | 0 | 0 | 1 |
Cell death-related nuclease 4 | 0 | 0 | 0 | 1 |
3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
endonuclease IV | 10 | 0 | 0 | 10 |
nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 4 | 0 | 0 | 4 |
steroidogenic factor 1 | 0 | 1 | 0 | 1 |
Tubulin alpha-1A chain | 0 | 2 | 1 | 3 |
Tubulin beta chain | 0 | 2 | 1 | 3 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Tubulin beta-4A chain | 0 | 3 | 2 | 6 |
ATP-dependent translocase ABCB1 | 0 | 6 | 0 | 6 |
Tubulin beta chain | 0 | 3 | 2 | 6 |
ATP-dependent translocase ABCB1 | 0 | 15 | 1 | 22 |
Tubulin alpha-3C chain | 0 | 3 | 2 | 6 |
Serine/threonine-protein kinase pim-1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 6 | 0 | 6 |
Tubulin alpha-1B chain | 0 | 3 | 2 | 6 |
Tubulin alpha-4A chain | 0 | 3 | 2 | 6 |
Tubulin beta-4B chain | 0 | 3 | 2 | 6 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Tubulin beta-3 chain | 0 | 3 | 2 | 6 |
Tubulin beta-2A chain | 0 | 3 | 2 | 6 |
Tubulin polymerization-promoting protein | 0 | 0 | 1 | 1 |
Tubulin beta-8 chain | 0 | 3 | 2 | 6 |
Tubulin beta-2B chain | 0 | 2 | 0 | 2 |
Tubulin alpha-3E chain | 0 | 3 | 2 | 6 |
Tubulin alpha-1A chain | 0 | 3 | 2 | 6 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
CREB-binding protein | 2 | 1 | 0 | 3 |
Tubulin alpha-1C chain | 0 | 3 | 2 | 6 |
Tubulin beta-6 chain | 0 | 3 | 2 | 6 |
Tubulin beta-2B chain | 0 | 3 | 2 | 6 |
Tubulin beta-1 chain | 0 | 3 | 2 | 6 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Phosphodiesterase | 0 | 4 | 0 | 4 |
Multidrug resistance-associated protein 5 | 0 | 1 | 0 | 2 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 6 | 0 | 6 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 6 | 0 | 6 |
Progesterone receptor | 0 | 4 | 0 | 5 |
Androgen receptor | 0 | 6 | 1 | 7 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 2 | 2 | 4 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
Lactoylglutathione lyase | 0 | 4 | 0 | 4 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 7 | 0 | 7 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Albumin | 0 | 9 | 12 | 24 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 5 | 5 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 5 | 3 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 5 | 2 | 7 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 2 | 0 | 2 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 4 | 4 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 4 | 2 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 4 | 2 | 6 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 4 | 3 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 7 | 0 | 7 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 7 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 3 | 0 | 3 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 5 | 0 | 5 |
Interleukin-8 | 0 | 3 | 0 | 3 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 5 | 2 | 7 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A4 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 3 | 0 | 3 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 4 |
UDP-glucuronosyltransferase 2B10 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent betaine transporter | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 4 | 2 | 7 |
5-hydroxytryptamine receptor 2A | 0 | 25 | 1 | 26 |
5-hydroxytryptamine receptor 2B | 0 | 28 | 1 | 29 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
Protein cereblon | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Prostacyclin receptor | 0 | 2 | 1 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 3 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 4 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 4 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 3 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 5 | 0 | 0 | 5 |
serine/threonine-protein kinase mTOR isoform 1 | 14 | 0 | 0 | 14 |
Interstitial collagenase | 0 | 3 | 0 | 3 |
Beta-2 adrenergic receptor | 0 | 8 | 5 | 14 |
Angiotensin-converting enzyme | 0 | 11 | 0 | 11 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 10 | 0 | 10 |
5-hydroxytryptamine receptor 1B | 0 | 16 | 1 | 17 |
N-acetyltransferase Eis | 0 | 1 | 0 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 3 | 0 | 3 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
NS5 | 0 | 0 | 1 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 4 | 0 | 0 | 4 |
Glucose transporter | 0 | 1 | 0 | 1 |
Serine hydrolase RBBP9 | 0 | 1 | 0 | 1 |
Hexose transporter 1 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 2 |
Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 2 |
Adenylate cyclase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 4 | 0 | 4 |
Beta-1 adrenergic receptor | 0 | 6 | 3 | 9 |
Thromboxane-A synthase | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 1D | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1B | 0 | 5 | 1 | 6 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
Chain A, GLUTATHIONE TRANSFERASE A1-1 | 0 | 1 | 0 | 1 |
Chain A, Glutathione S-transferase P1-1 | 0 | 1 | 0 | 1 |
Chain A, Glutathione S-transferase P1-1 | 0 | 1 | 0 | 1 |
Chain B, Glutathione S-transferase P1-1 | 0 | 1 | 0 | 1 |
WRN | 3 | 0 | 0 | 3 |
isocitrate dehydrogenase 1, partial | 2 | 0 | 0 | 2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 5 | 0 | 0 | 5 |
serine-protein kinase ATM isoform a | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase PLK1 | 7 | 0 | 0 | 7 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 3 | 1 | 0 | 4 |
Hematopoietic prostaglandin D synthase | 0 | 1 | 0 | 1 |
Glutathione S-transferase A1 | 0 | 1 | 0 | 1 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 1 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 2 | 0 | 2 |
UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
14 kDa phosphohistidine phosphatase | 0 | 2 | 0 | 2 |
large T antigen | 0 | 2 | 0 | 2 |
Pantothenate synthetase | 0 | 2 | 0 | 2 |
Estrogen receptor | 0 | 6 | 3 | 11 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
Aldehyde oxidase | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 5 | 1 | 6 |
peripheral myelin protein 22 isoform 1 | 11 | 0 | 0 | 11 |
M-phase phosphoprotein 8 | 13 | 0 | 0 | 13 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Peroxisome proliferator-activated receptor alpha | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 4 | 4 |
D(4) dopamine receptor | 0 | 6 | 0 | 6 |
Mu-type opioid receptor | 0 | 4 | 2 | 9 |
Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 3 |
Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 2 |
Histamine H4 receptor | 0 | 2 | 0 | 2 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
hemoglobin subunit beta | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 2 |
Arylacetamide deacetylase | 0 | 1 | 0 | 4 |
Arylacetamide deacetylase | 0 | 0 | 0 | 2 |
Arylacetamide deacetylase | 0 | 0 | 0 | 2 |
UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
Menin | 0 | 0 | 1 | 1 |
Lecithin retinol acyltransferase | 0 | 1 | 0 | 1 |
Lethal factor | 0 | 1 | 0 | 1 |
Protein Rev | 0 | 0 | 1 | 1 |
Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 1 | 1 | 2 |
Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 1 | 0 | 2 |
Bile acid receptor | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 3 | 0 | 3 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 3 | 0 | 3 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 3 | 0 | 3 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 4 | 0 | 4 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 6 | 2 | 8 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 6 | 2 | 8 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 6 | 2 | 9 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 6 | 2 | 8 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 6 | 2 | 8 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 6 | 2 | 8 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 7 | 0 | 0 | 7 |
Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
Mcl-1 | 0 | 2 | 0 | 2 |
MPI protein | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
luciferase | 1 | 0 | 0 | 1 |
pyruvate kinase | 2 | 0 | 0 | 2 |
CDK5 | 0 | 0 | 0 | 1 |
major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
Vif | 0 | 1 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Endothelin-1 receptor | 1 | 1 | 0 | 2 |
phosphoglycerate kinase | 3 | 0 | 0 | 3 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
Hsf1 protein | 0 | 0 | 4 | 5 |
Chain A, Purine-nucleoside Phosphorylase | 0 | 1 | 0 | 1 |
Chain C, Xanthine dehydrogenase/oxidase | 0 | 0 | 1 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 5 |
Aldo-keto reductase family 1 member C3 | 0 | 3 | 0 | 3 |
Caspase-3 | 0 | 3 | 0 | 3 |
Caspase-4 | 0 | 3 | 0 | 3 |
Caspase-5 | 0 | 3 | 0 | 3 |
Caspase-9 | 0 | 3 | 0 | 3 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain A, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain B, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Substance-K receptor | 0 | 4 | 0 | 4 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 0 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
Protease | 0 | 5 | 3 | 10 |
Protease | 0 | 1 | 0 | 1 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 6 | 0 | 6 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 2 | 0 | 3 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
Peptidylglycine alpha-amidating monooxygenase | 0 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
Isocitrate lyase | 0 | 1 | 0 | 1 |
Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 2 | 5 |
beta-2 adrenergic receptor | 3 | 0 | 0 | 3 |
hexokinase-4 isoform 1 | 3 | 0 | 0 | 3 |
glucokinase regulatory protein | 3 | 0 | 0 | 3 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 2 | 2 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-2 adrenergic receptor | 0 | 3 | 0 | 3 |
Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 2 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 2 | 3 |
Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 3 | 7 |
Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 13 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 2 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
Capsid protein | 0 | 1 | 1 | 2 |
Gonadotropin-releasing hormone receptor | 0 | 1 | 0 | 1 |
Gonadotropin-releasing hormone receptor | 0 | 2 | 0 | 2 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Synaptic vesicle glycoprotein 2A | 0 | 2 | 0 | 2 |
CAAX prenyl protease 2 isoform 2 | 0 | 0 | 0 | 1 |
DNA primase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Neprilysin | 0 | 1 | 0 | 1 |
Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 2 | 1 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 4 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 5 | 0 | 5 |
Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 3 | 2 | 7 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
corticotropin-releasing hormone receptor 2 | 0 | 1 | 1 | 2 |
corticotropin releasing factor-binding protein | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Cyclin-dependent kinase 2 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 3 | 0 | 3 |
Cystathionine gamma-lyase | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
D | 0 | 4 | 0 | 4 |
D(3) dopamine receptor | 0 | 4 | 0 | 4 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 1 | 3 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 3D | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
voltage-dependent T-type calcium channel subunit alpha-1H isoform a | 0 | 0 | 1 | 1 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 4 | 0 | 4 |
Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
Chain A, Gyrase | 0 | 0 | 1 | 1 |
Genome polyprotein | 0 | 1 | 1 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 0 | 2 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Cell division inhibitor SulA | 0 | 0 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90 | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
DNA topoisomerase | 0 | 1 | 0 | 1 |
Microtubule-associated proteins 1A/1B light chain 3B | 0 | 2 | 1 | 3 |
Microtubule-associated proteins 1A/1B light chain 3A | 0 | 2 | 1 | 3 |
STE24 | 0 | 0 | 0 | 1 |
Trypsin | 0 | 0 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE | 0 | 1 | 0 | 1 |
Chain A, Pyruvate kinase, M2 isozyme | 0 | 1 | 0 | 1 |
Chain A, Phosphonopyruvate hydrolase | 0 | 1 | 0 | 1 |
Chain A, Phosphoenolpyruvate-protein phosphotransferase | 0 | 1 | 0 | 1 |
polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
chaperonin GroEL | 1 | 0 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 7 | 0 | 7 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 3 | 0 | 4 |
Alpha-2C adrenergic receptor | 0 | 3 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 3 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Nischarin | 0 | 2 | 0 | 2 |
Microphthalmia-associated transcription factor | 0 | 0 | 0 | 1 |
caspase recruitment domain family, member 15 | 0 | 1 | 0 | 1 |
receptor-interacting serine/threonine-protein kinase 2 isoform 1 | 0 | 1 | 0 | 1 |
Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 2 | 0 | 2 |
Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 3 | 0 | 3 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 3 | 0 | 3 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 3 |
Succinyl-diaminopimelate desuccinylase | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 0 | 0 | 2 |
Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
ClpP | 1 | 0 | 0 | 1 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
fMet-Leu-Phe receptor | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
Phenylethanolamine N-methyltransferase | 0 | 0 | 0 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
Beta-casein | 0 | 1 | 0 | 1 |
Alpha-mannosidase 2C1 | 0 | 0 | 1 | 1 |
Bromodomain-containing protein 2 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Histamine H1 receptor | 0 | 1 | 1 | 2 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 2 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Calmodulin | 0 | 0 | 1 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 3 | 3 |
Pyridoxal kinase | 0 | 0 | 0 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
Chromaffin granule amine transporter | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 2 | 0 | 2 |
Synaptic vesicular amine transporter | 0 | 2 | 1 | 3 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
NH(3)-dependent NAD(+) synthetase | 0 | 2 | 0 | 2 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
Protein-arginine deiminase type-4 | 0 | 6 | 0 | 6 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Aurora kinase A | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
ATP-dependent 6-phosphofructokinase | 0 | 1 | 0 | 1 |
Dihydropteroate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 4 |
Cystine/glutamate transporter | 0 | 2 | 0 | 2 |
Chain A, Glutathione S-transferase | 0 | 1 | 0 | 1 |
Tumor necrosis factor | 0 | 0 | 1 | 1 |
Fibroblast growth factor 1 | 0 | 0 | 1 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 1 | 0 | 1 |
fMet-Leu-Phe receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 12 | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 1 | 2 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 2 | 0 | 2 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
XBP1 | 0 | 1 | 0 | 1 |
DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 2 | 0 | 2 |
C-C chemokine receptor type 5 | 0 | 2 | 0 | 2 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Chain A, ykoF | 0 | 0 | 1 | 1 |
Chain B, ykoF | 0 | 0 | 1 | 1 |
Chain A, ThiT | 0 | 0 | 1 | 1 |
Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
Transketolase | 0 | 0 | 1 | 1 |
Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate Reductase | 0 | 0 | 1 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, dihydrofolate reductase (DHFR) | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase type 1 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase type 1 from Tn4003 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 5 | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Trace amine-associated receptor 5 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
Ricin | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 0 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 2 | 0 | 3 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
DNA polymerase beta | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Amine oxidase [flavin-containing] | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |